A Study to Assess the Safety and Tolerability of RC88 for Patients With Advanced Solid Tumours
Clinical trial NCT05508334 · COMPLETED
Trial details
- NCT number
- NCT05508334
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-30
- Primary completion
- 2025-11-26
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.